• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of molecular basis for occurance of Hodgkin lympnoma and anaplastic large cell lymphoma

Research Project

Project/Area Number 18590345
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionKitasato University

Principal Investigator

HORIE Ryouichi  Kitasato University, School of Medicine, Associate Prof. (80229228)

Co-Investigator(Kenkyū-buntansha) HIGASHIHARA Masaaki  Kitasato University, School of Medicine, Prof (80165084)
WATANABE Toshiki  University of Tokyo, Graduate School of Frontier Sciences, Prof (30182934)
Project Period (FY) 2006 – 2007
Project Status Completed (Fiscal Year 2007)
Budget Amount *help
¥4,010,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥510,000)
Fiscal Year 2007: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2006: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsHodgkin lymphoma / anaplastic large cell lymphoma / NF-κB / NPM-ALK / P80 / JunB / NF-kB
Research Abstract

High expression of CD30 and JunB is characteristic of tumor cells in anaplastic large cell lymphoma (ALCL) and Hodgkin lymphoma (HL). The possible inter-relationships of CD30 and JunB were examined in this study. We found that the CD30 promoter in tumor cells of both nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) positive and NPM-ALK negative ALCL and HL is regulated by a constitutively active CD30-extracellular signal-regulated kinase (ERK) 1/2 mitogen-activated protein kinase (MAPK). Phosphorylated ERK1/2 MAPK was confirmed in nuclei of tumor cells in biopsies of ALCL and HL. CD30-ERK1/2 MAPK signals induce JunB expression which maintains high activity of the CD30 promoter. JunB induction appears to be largely independent of NF-KB in ALCL and HL. These results demonstrate a common mechanism of CD30 overexpression in ALCL and HL although the results of CD30 signaling differ between NPM- ALK positive ALCL and other subgroups ; NPM-ALK negative ALCL, cutaneous ALCL and HL as we recently reported.

Report

(3 results)
  • 2007 Annual Research Report   Final Research Report Summary
  • 2006 Annual Research Report
  • Research Products

    (23 results)

All 2007 2006

All Journal Article (21 results) (of which Peer Reviewed: 10 results) Presentation (2 results)

  • [Journal Article] Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation inmice inoculated with tax-deficient adult T-cell leukemia-derived cell lines2007

    • Author(s)
      Ohsugi T, 4名, Horie R, 2名
    • Journal Title

      Cancer Lett 257

      Pages: 206-215

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] TRAF activation of C/EBPb (NF-IL6) via p38 MAPK induces HIV-1 gene expre ssion in monocvtes/macrophages2007

    • Author(s)
      Horie R, 8名
    • Journal Title

      Microbes Infect 48

      Pages: 721-728

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] IkBalpa independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin-Reed-Stemberg cells2007

    • Author(s)
      Watanabe M, 10名, Horie R
    • Journal Title

      Lab Invest 87

      Pages: 372-382

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Dehydroxymethylepoxyquinomicin(DHMEQ)therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines2007

    • Author(s)
      Ohsugi, T, Kumasaka, T, Okada, S, Ishida, T, Yamaguchi, K, Horie, R, Watanabe, T, Umezawa, K
    • Journal Title

      Cancer Lett 257(2)

      Pages: 206-15

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] TRAF activation of C/EBPb (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages2007

    • Author(s)
      Horie, R, Ishida, T, Maruyama-Nagai, M, Ito, K, Watanabe, M, Yoneyama, A, Higashihara, M, Kimura, S, Watanabe, T
    • Journal Title

      Microbes Infect 48

      Pages: 721-8

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] IkBalpa independent induction of NF-kappaB and its inhibition b DHMEQ in Hodgkin-Reed-Sternberg cells2007

    • Author(s)
      Watanabe, M, Dewan, MZ, Taira, M, Shoda, M, Honda, M, Sata, T, Higashihara, M, Kadin, ME, Watanabe, T, Yamamoto, N, Umezawa, K, Horie, R
    • Journal Title

      Lab Invest 87

      Pages: 372-82

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Dehydroxymethylepoxyquinomicin(DHMEQ)therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.2007

    • Author(s)
      Ohsugi T, 4名, Horie R, 2名
    • Journal Title

      Cancer Lett. 257

      Pages: 206-215

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] TRAF activation of C/EBPb(NF-IL6)via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages.2007

    • Author(s)
      Horie R, 8名
    • Journal Title

      Microbes Infect. 48

      Pages: 721-728

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] IkBalpa independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin-Reed-Sternberg cells.2007

    • Author(s)
      Watanabe M, 10名, Horie R
    • Journal Title

      Lab Invest. 87

      Pages: 372-382

    • Related Report
      2007 Annual Research Report
    • Peer Reviewed
  • [Journal Article] DHMEQ,a new NF-kappaB inhibitor,induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells2006

    • Author(s)
      HorieR, 他9名
    • Journal Title

      Leukemia 20(5)

      Pages: 800-6

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma2006

    • Author(s)
      Hone R, Watanabe T, Umezawa K.
    • Journal Title

      Drug News Perspect 19(4)

      Pages: 201-9

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma2006

    • Author(s)
      Uchihara JN-4名-Horie R, 他4名
    • Journal Title

      Int J Cancer 118(5)

      Pages: 1098-107

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human cell leukemia virus type I-infected cell line,HUT-1022006

    • Author(s)
      Ohsugi T-3名-Horie R, 他3名
    • Journal Title

      Leuk Res 30(1)

      Pages: 90-7

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Final Research Report Summary
    • Peer Reviewed
  • [Journal Article] DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells2006

    • Author(s)
      Horie, R, Watanabe, M, Okamura, T, Taira, M, Shoda, M, Motoji, T, Utsunomiya, A, Watanabe, T, Higashihara, M, Umezawa, K
    • Journal Title

      Leukemia 20

      Pages: 800-806

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma2006

    • Author(s)
      Horie, R, Watanabe, T, Umezawa, K
    • Journal Title

      Drug News Perspect

      Pages: 201-209

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma2006

    • Author(s)
      Uchihara, JN, Matsuda, T, Okudaira, T, Ishikawa, C, Masuda, M, Rorie, R, Watanabe, T, Ohta, T, Takasu, N, Mori, N
    • Journal Title

      Int J Cancer 118

      Pages: 1098-1107

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-1022006

    • Author(s)
      Ohsugi, T, Kumasaka, T, Ishida, A, Ishida, T, Rorie, R, Watanabe, T, Umezawa, K, Yamaguchi, K
    • Journal Title

      Leuk Res 30

      Pages: 90-97

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary
  • [Journal Article] DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lvmnhocvtic leukemia cells.2006

    • Author(s)
      Horie R 他9名
    • Journal Title

      Leukemia 20(5)

      Pages: 800-6

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.2006

    • Author(s)
      Horie R, Watanabe T, Umezawa K
    • Journal Title

      Drug News Perspect 19(4)

      Pages: 201-9

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.2006

    • Author(s)
      Uchihara JN-4名, Horie R 他4名
    • Journal Title

      Int J Cancer. 118(5)

      Pages: 1098-107

    • Related Report
      2006 Annual Research Report
  • [Journal Article] In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102.2006

    • Author(s)
      Ohsugi T-3名-, Horie R 他3名
    • Journal Title

      Leuk Res. 30(1)

      Pages: 90-7

    • Related Report
      2006 Annual Research Report
  • [Presentation] 変異型IkBaを有するH-RS細胞でのIkBbを介したNF-kB誘導とDHMEQによる分子標的療法2007

    • Author(s)
      堀江 良一, 他8名
    • Organizer
      第49回日本臨床血液学会総会
    • Place of Presentation
      横浜
    • Year and Date
      2007-10-12
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2007 Annual Research Report 2007 Final Research Report Summary
  • [Presentation] Targeting of constitutive NF-KB activation in transformed and untransformed HTLV-1-infected T cells by DHMEQ : A strategy for chemoprevention and therapy of adult T-cell leukemia. Int J Mol. Med2006

    • Author(s)
      R., Horie
    • Organizer
      The 11th world Congress on Advances in Oncology, 9 th International Symposium on Molecular Medicine
    • Place of Presentation
      Hersonissos, Crete, Greece
    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2007 Final Research Report Summary

URL: 

Published: 2006-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi